BOSTON, Jan. 08, 2026 -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed...
Art Pappas will sit on a panel at the Biotechnologia 2007 Conference, in Greece, titled "IPOs and IPO-like Transactions in Global Markets".
News | 07. 11. 2008
